Nanoparticle T cell engagers for the treatment of acute myeloid leukemia

Authors

Kinan Alhallak, Washington University School of Medicine in St. Louis
Jennifer Sun, Washington University School of Medicine in St. Louis
Barbara Muz, Washington University School of Medicine in St. Louis
Amanda Jeske, Washington University School of Medicine in St. Louis
Jessica Yavner, Washington University School of Medicine in St. Louis
Hannah Bash, Washington University School of Medicine in St. Louis
Chaelee Park, Washington University School of Medicine in St. Louis
Berit Lubben, Washington University School of Medicine in St. Louis
Ola Adebayo, Washington University School of Medicine in St. Louis
Samuel Achilefu, Washington University School of Medicine in St. Louis
John F DiPersio, Washington University School of Medicine in St. Louis
Abdel Kareem Azab, Washington University School of Medicine in St. Louis

Journal

Oncotarget

Publication Date

9-14-2021

Volume

12

Issue

19

First Page

1878

Last Page

1885

Document Type

Open Access Publication

DOI

10.18632/oncotarget.28054

Rights and Permissions

Alhallak K, Sun J, Muz B, Jeske A, Yavner J, Bash H, Park C, Lubben B, Adebayo O, Achilefu S, DiPersio JF, Azab AK. Nanoparticle T cell engagers for the treatment of acute myeloid leukemia. Oncotarget. 2021 Sep 14;12(19):1878-1885. doi: 10.18632/oncotarget.28054. © 2021 Alhallak et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Alhallak, Kinan; Sun, Jennifer; Muz, Barbara; Jeske, Amanda; Yavner, Jessica; Bash, Hannah; Park, Chaelee; Lubben, Berit; Adebayo, Ola; Achilefu, Samuel; DiPersio, John F; and Azab, Abdel Kareem, "Nanoparticle T cell engagers for the treatment of acute myeloid leukemia." Oncotarget. 12, 19. 1878 - 1885. (2021).
https://digitalcommons.wustl.edu/oa_4/516